Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis
Sebastian Torben Jendrek(University of Lübeck), Christian Sina(Khalifa University of Science and Technology), Peter Schemmer(Heidelberg University), Evaggelia Liaskou(Cancer Research UK Clinical Trials Unit), Bianca Teegen(Mayo Clinic), Tom H. Karlsen(Oslo University Hospital), Klaus Fellermann(Apple (Israel)), Mette Vesterhus(Deaconess Hospital), Stefanie Derer(Universitäres Kinderwunschzentrum Lübeck), Lars Komorowski(Euroimmun Medizinische Labordiagnostika (Germany)), Tobias Korf(University of Lübeck), Thomas Nitzsche(Euroimmun Medizinische Labordiagnostika (Germany)), Marc Ehlers(University Hospital Schleswig-Holstein), Christoph M. Hammers(University of Regensburg), Hendrik Lehnert(University of Salzburg), Laila Widmann(Heidelberg University), Johannes R. Hov(Oslo University Hospital), Swantje Mindorf(Mayo Clinic), Daniel Gotthardt(Heidelberg University), Torsten Schröder(University Hospital Schleswig-Holstein), Maike Anna Michaels(University of Lübeck), Karl-Heinz Weiss(Heidelberg University), Florian Bär(University of Lübeck)
Cited by 84
Related Papers
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969
NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
|Gut|2004|798
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
|The Lancet|2015|779
A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon
|The American Journal of Human Genetics|2006|566